Prophylaxis in congenital coagulation disorders: past, present and future.
Mannucci
Pier Mannuccio
PM
Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Università degli Studi di Milano, Milano, Italia. piermannuccio.mannucci@unimi.it
D025861:Blood Coagulation Disorders, Inherited / Q000150:complications / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000600:supply & distribution / Q000627:therapeutic use*; D015942:Factor VIIa / Q000627:therapeutic use; D006395:Hemarthrosis / Q000209:etiology / Q000517:prevention & control; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007223:Infant; D008297:Male; D010641:Phenotype; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D014842:von Willebrand Diseases / Q000628:therapy
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa